Periyodik Paraliziler
Özet
Periyodik paraliziler, ağır egzersiz, oruç veya karbonhidrat ağırlıklı beslenme gibi faktörlerle tetiklenen, ağrısız kas güçsüzlüğü atakları ile karakterize nadir bir nöromüsküler bozukluk grubudur. Serum potasyum seviyelerine göre hipokalemik ve hiperkalemik olarak sınıflandırılan bu hastalıklar, genellikle genetik kökenli olup iskelet kası kanalopati ailesinde yer alırlar. Ataklar sırasında hastaların bilinci korunurken, solunum ve bulbar kaslar genellikle etkilenmez, ancak tirotoksikoz gibi ikincil nedenler veya farklı sendromlarla ayırıcı tanısının yapılması kritik öneme sahiptir. Tedavide yaşam tarzı düzenlemeleri, potasyum takviyeleri ve belirli diüretik veya karbonik anhidraz inhibitörleri gibi farmakolojik yöntemler tercih edilmektedir.
Periodic paralyses are a group of rare neuromuscular disorders characterized by episodes of painless muscle weakness, often triggered by intense exercise, fasting, or high-carbohydrate meals. Classified based on serum potassium levels into hypokalemic and hyperkalemic types, these conditions are primarily genetic channelopathies, though secondary causes such as thyrotoxicosis can also precipitate attacks. During episodes, patients maintain consciousness and typically experience minimal involvement of bulbar or respiratory muscles, though differential diagnosis is essential to distinguish these from other systemic causes. Management strategies include lifestyle modifications, potassium supplementation, and pharmacological interventions such as diuretics or carbonic anhydrase inhibitors.
Referanslar
Statland JM, Fontaine B, Hanna MG, et al. Review of the Diagnosis and Treatment of Periodic Paralysis. Muscle Nerve. 2018; 57:522-530.
Miller TM, Dias da Silva MR, Miller HA, et al. Correlating phenotype and genotype in the periodic paralyses. Neurology. 2004; 63:1647-1655.
Pina-garza JE. Flaccid Limb Weakness İn Childhood. Fenichel’s clinical pediatric neurology. Seventh edition. p.188-193.
Ke Q, Luo B, Qi M, Du Y, Wu W. Gender differences in penetrance and phenotype in hypokalemic periodic paralysis. Muscle Nerve. 2013; 47:41.
Matthews E, Labrum R, Sweeney MG et all. Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. Neurology. 2009;5;72(18):1544-1570.
Fouad G, Dalakas M, Servidei S, et al. Genotype-phenotype correlations of DHP receptor alpha 1-subunit gene mutations causing hypokalemic periodic paralysis. Neuromusculer Disorder. 1997; 7: 33-38.
Gutmann L, Conwit R. Up to date. Hypokalemic periodic paralysis. May 2021.
Venance SL, Cannon SC, Fialho D, et al. The primary periodic paralyses: diagnosis, pathogenesis and treatment. Brain. 2006; 129: 8-17
Links TP, Zwarts MJ, Wilmink JT,Molenaar WM, Oosterhuis HJ. Permanent muscle weakness in familial hypokalaemic periodic paralysis. Clinical, radiological and pathological aspects. Brain. 1990; 113 (Pt 6):1873.
Gutmann L, Conwit R. Up to date. Thyrotoxic periodic paralysis. May 2021.
Wong GW, Leung TF, Lo AF, Ahuja AT, Cheng PS. Thyrotoxic periodic paralysis in a 14-year-old boy. Eur J Pediatr. 2000; 159:934.
Ober KP. Thyrotoxic periodic paralysis in the United States. Report of 7 cases and review of the literature. Medicine (Baltimore). 1992; 71:109.
Mellgren G, Bleskestad HI, Aanderud S, Bindoff L. Thyrotoxicosis and paraparesis in a young woman: case report and review of the literature. Thyroid. 2002;12(1):77–80.
Lin SH, Lin YF, Chen DT, Chu P, Hsu CW, Halperin ML. Laboratory tests to determine the cause of hypokalemia and paralysis. Arch Intern Med. 2004; 164:1561.
Lin SH, Lin YF, Halperin ML. Hypokalaemia and paralysis. QJM. 2001; 94:133.
Ng HY, Lin SH, Hsu CY, Tsai YZ, Chen HC, Lee CT. Hypokalemic paralysis due to Gitelman syndrome: a family study. Neurology. 2006; 67:1080.
McManis PG, Lambert EH, Daube JR. The exercise test in periodic paralysis. Muscle Nerve. 1986; 9:704.
Griggs RC, Resnick J, Engel WK. Intravenous treatment of hypokalemic periodic paralysis. Arch Neurol. 1983; 40:539.
Gutmann L, Conwit R. Up to date. Hyperkalemic periodic paralysis. May 2021.
Farooque U, Cheema AY, Kumar R, Saini G, Kataria S. Primary Periodic Paralyses: A Review of Etiologies and Their Pathogeneses. Cureus. 2020; 12(8): e10112.
Finsterer J. Primary periodic paralyses. Acta Neurol Scand.2008;117:145-158
Gould RJ, Steeg CN, Eastwood AB, Penn AS, Rowland LP, De Vivo DC. Potentially fatal cardiac dysrhythmia and hyperkalemic periodic paralysis. Neurology. 1985; 35:1208.
Yoon G, Oberoi S, Tristani‐Firouzi M, et al. Andersen‐Tawil syndrome: prospective cohort analysis and expansion of the phenotype. Am J Med Genet A. 2006; 140:312.
